Many Americans support stem cell research but are unwilling to give drug companies a blank taxpayer check to develop it without appropriate controls. About a dozen states have passed or are considering taxpayer subsidized programs for stem cell research. Proponents of California's Prop 71 stem cell program promised that all Californians would have access to new medical breakthroughs and that the state would receive royalties that would payback the public's investment.

The California stem cell oversight board, rife with conflicts-of-interests with private companies and universities seeking research grants, could make matters much worse if drug companies are allowed to control new medical technologies developed with taxpayer funds.

Read about Consumer Watchdog's work to make sure that the public receives a return on their investment. One entity, the Wisconsin Alumni Research Foundation (WARF), owns the patents to all human patents.

Read about Consumer Watchdog's efforts to remove roadblocks to research by stripping overreaching patents.